Beijing Wantai Biological Pharmacy Enterprise (603392.SH): Application for clinical trial of recombinant respiratory syncytial virus vaccine (CHO cells) accepted.

16:22 17/12/2025

Wan Tai Biology (603392.SH) announced that its wholly-owned subsidiary Xiamen Wan Tai Canghai Biotechnology Co., Ltd. has received the administrative licensing document "Acceptance Notice" from the National Medical Products Administration (referred to as the "NMPA"). The clinical trial application for the "Recombinant Respiratory Syncytial Virus Vaccine (CHO Cells)" submitted by the company has been accepted.

Beijing Wantai Biological Pharmacy Enterprise (603392.SH) announced that its wholly-owned subsidiary, Xiamen Wantai Canghai Biotechnology Co., Ltd., has received an administrative license document from the National Medical Products Administration (referred to as the "NMPA") titled "Notice of Acceptance", indicating that the company's application for clinical trials of the "Recombinant Respiratory Syncytial Virus Vaccine (CHO Cell)" has been accepted.

Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!

Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.

Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.

Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!

Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.

Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.